Introduction
The mature adults of Angiostrongylus cantonensis are zoonotic nematodes that thrive in the pulmonary arteries of rats. Non-permissive hosts, such as humans, may unintentionally ingest third-stage (L3) nematode larvae through food, such as snails, slugs or raw or undercooked vegetables (Alto, Reference Alto2001). Angiostrongylus cantonensis causes angiostrongyliasis, which is characterized by severe central nervous system (CNS) inflammation, eosinophilic meningitis and eosinophilic meningoencephalitis (Hsu et al., Reference Hsu, Chen, Chien, Chi and Han1990; Ismail and Arsura, Reference Ismail and Arsura1993; Alto, Reference Alto2001). The parasite has been found to infect humans and other mammals, with a wide and ever-increasing distribution across regions such as East Asia, Southeast Asia, the Pacific Islands and the Caribbean (Wang et al., Reference Wang, Ren, Zhang, Lu and Chen2018). Worldwide, A. cantonensis infection cases occur every year. According to a review published in 2008, nearly 3000 cases of human angiostrongyliasis have been documented worldwide (Wang et al., Reference Wang, Lai, Zhu, Chen and Lun2008). However, this number has risen rapidly in recent years. In a prospective descriptive study conducted from June 2008 to January 2014 in a Vietnamese hospital, A. cantonensis was found to be an important cause of eosinophilic meningitis, accounting for 67.3% (37/55) of the cases (McBride et al., Reference McBride, Chau, Hong, Mai, Anh, Thanh, Van, Xuan, Sieu, Thai, Chuong, Sinh, Phong, Phu, Day, Nghia, Hien, Chau, Thwaites and Tan2017). These outbreaks have caused great concern regarding the treatment for A. cantonensis infection among the general public. Therefore, research on A. cantonensis is crucial and of significant socioeconomic importance globally. Thus, identifying a new strategy to suppress A. cantonensis-mediated CNS inflammation, eosinophilic meningitis and eosinophilic meningoencephalitis is critical.
Many inflammatory mediators are linked to several inflammatory diseases, including CNS inflammation. Previous studies have demonstrated that the inflammatory mediators cyclooxygenase-2 (COX-2) (Crofford, Reference Crofford1997), tumour necrosis factor-α (TNF-α) (Vassalli, Reference Vassalli1992), interleukin-1β (IL-1β) (McAfoose and Baune, Reference McAfoose and Baune2009), matrix metalloproteinase-9 (MMP-9) (Stamenkovic, Reference Stamenkovic2003) and nuclear factor (NF)-κB (Kaltschmidt et al., Reference Kaltschmidt, Widera and Kaltschmidt2005) are expressed at low levels under normal physiological conditions and are highly induced in response to inflammation or pathological processes. Moreover, an increasing number of studies have revealed that TNF-α, IL-1β (Tu and Lai, Reference Tu and Lai2006), MMP-9 (Chen et al., Reference Chen, Lee, Lu, Tseng, Hsu, Chou and Lai2004) and NF-κB (Chiu and Lai, Reference Chiu and Lai2013) may participate in the pathogenesis of CNS inflammation during A. cantonensis infection.
Calycosin represents the major isoflavonoid in Huang Qi (Radix Astragali Mongolici), a traditional Chinese herbal medicine (Li et al., Reference Li, Zhang and Zhang2011). Calycosin can exhibit anti-inflammatory mediator- or cytokine-like activity, including decrease in the COX-2, IL-1β and TNF-α, as well as mediates NF-κB signalling (Hoo et al., Reference Hoo, Wong, Qiao, Xu, Xu and Lam2010; Su et al., Reference Su, Huang, Chen, Wang, Pan, Wang, Zhou, Zhou, Liu, Yang, Li and Liu2016; Dong et al., Reference Dong, Yin, Chen, Zhang, Hua, Quan and Fu2018). However, no study has delineated the potential of calycosin in A. cantonensis-induced CNS inflammation. With this in mind, the current study was carried out to explore whether calycosin could ameliorate A. cantonensis-induced CNS inflammation and eosinophilic meningitis and thereby ascertain the underlying mechanisms.
Materials and methods
Chemical reagents and antibodies
The antibodies used in this study were anti-MMP-9, anti-phospho-NF-κB (p-P65), anti-COX-2 and anti-β-actin (Santa Cruz Biotechnology Inc., CA, USA). Haem oxygenase-1 (HO-1) was obtained from Abclonal Company, Inc. (MA, USA). Albendazole (ABZ), an anthelmintic or anti-worm medication, and calycosin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Tin-protoporphyrin IX (SnPPIX) was purchased from Cayman Chemical (Ann Arbor, Michigan, USA). ABZ was dissolved in a normal saline solution. Calycosin and SnPPIX were dissolved in dimethyl sulphoxide and administered to the animals at a final concentration of <0.1%.
Experimental animals
We used 5-week-old male BALB/c mice to establish the A. cantonensis-infected mouse model. The mice were purchased from the National Laboratory Animal Center (Taipei, Taiwan) and housed under a 12 h light and dark cycle with free access to water and food.
Animal infection protocol
The third-stage larvae (L3, infective larvae) of A. cantonensis were obtained from naturally infected giant African snails (Achatina fulica) that were purchased from Heping District (Taichung, Taiwan) (Chin et al., Reference Chin, Chen, Lee, Chou and Lu2018). The larvae were liberated from the minced snail tissues by pepsin (Sigma, USA) digestion. The identity of the L3 larvae of A. cantonensis was confirmed as described earlier (Ash, Reference Ash1970). To assess whether the larvae found were A. cantonensis, we fed them to rats and then examined the rat brains after 2–3 weeks for evidence of infection. In this study, food and water were prohibited for 12 h before infection. Thirty male BALB/c mice were randomly allocated to 6 groups (control, and days 6, 12, 18, 24 and 30) of 5 mice each. Mice in the 5 experimental groups (days 6, 12, 18, 24 and 30) were infected with 50 A. cantonensis larvae by oral inoculation and were sacrificed on days 6, 12, 18, 24 or 30 post-infection (PI). Control mice received only water and were euthanized on day 30 PI.
Animal treatment
Twenty mice were randomly divided into 4 treatment groups (5 mice per group). The 4 groups were treated with ABZ (10 mg kg−1 day−1, oral administration), calycosin (30 mg kg−1 day−1, intraperitoneal administration), ABZ (10 mg kg−1 day−1, oral administration) combined with calycosin (30 mg kg−1 day−1, intraperitoneal administration) and SnPPIX (15 mg kg−1 day−1, intraperitoneal administration) combined with ABZ (10 mg kg−1 day−1, oral administration) and calycosin (30 mg kg−1 day−1, intraperitoneal administration), respectively, for 19 consecutive days. Drug administration was initiated on days 6–24 after infection. All mice were killed 25 days after inoculation.
Brain and blood sample collection
The brains were dissected, placed in powdered dry ice and stored at −80 °C. Coronal sections (20 μm) at the level of the striatum were cut on a cryostat at −18 °C, collected on glass slides coated with Vectabond (Vector Labs, Newark, CA, United States) and stored at −80 °C until immunostaining. All brain tissue extracts from each group were obtained by homogenizing in a lysis buffer (0.05 m Tris-HCl, pH 7.4, 0.15 m NaCl, 0.25% deoxycholic acid, 1% NP-40, 1 mm EDTA) containing the following protease inhibitors: 0.1 mm PMSF, 10 μ m sodium orthovanadate and 20 μg mL−1 leupeptin at a ratio of 100 mg tissue mL−1 lysis buffer. The homogenates were placed on ice and centrifuged at 10 000 g (for 30 min at 4 °C). The supernatants were collected and stored at −80 °C for further experiments.
Western blotting
Western blotting analyses were carried out as previously described, with slight modifications (Chin et al., Reference Chin, Chen, Lee, Chou and Lu2018; Lin et al., Reference Lin, Chen, Tsai, Tsai, Huang, Tang, Yang, Hsu, Peng and Chung2019; Liu et al., Reference Liu, Shibu, Tsai, Hsu, Tsai, Chung, Yang, Tang, Wang, Li and Huang2020; Chang et al., Reference Chang, Tsai, Yang, Hsu, Shih, Chiu, Bau and Tsai2021). Protein concentrations in the homogenates were then determined using the Bradford assay (Bio-Rad, Hercules, CA, USA). Thereafter, the protein samples were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis. The resolved proteins were transferred to polyvinylidene fluoride membranes (Merck Millipore, MA, USA). The membranes were blocked with 5% defatted milk in phosphate-buffered saline (PBS) (pH 7.4) and then exposed to the appropriate antibodies. All bands were visualized with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, California, USA) using an enhanced chemiluminescence system (Merck Millipore, MA, USA).
Enzyme-linked immunosorbent assay
TNF-α and IL-1β levels were measured using TNF-α (ab100785) and IL-1β (ab100768) enzyme-linked immunosorbent assay (ELISA) kits (Abcam, MA, USA), respectively, in accordance with the manufacturer's protocol. Fluorescence was measured on a microplate reader at excitation/emission wavelengths of 488/535 nm. ELISA was performed as described previously with slight modifications (Lu et al., Reference Lu, Day, Kuo, Wang, Ho, Lai, Chen, Yao, Viswanadha, Kuo and Huang2022).
Worm recovery
For larval recovery, the brain of each mouse was dissected into small pieces and homogenized separately in 15 mL of 0.25% sodium citrate in PBS, followed by centrifugation (1400 g, 10 min). Larvae were counted by visualizing at 25× magnification using a dissection microscope as described previously (Chen et al., Reference Chen, Lan and Lai2022).
Histology
Mouse brains were immediately removed and fixed in 10% neutral-buffered formalin for 24 h. The fixed brains were dehydrated in a graded ethanol series (50, 75, 95 and 100%), replaced with xylene, and embedded in paraffin at 55 °C for 24 h. Several serial sections were cut at 10 μm thickness and stained with haematoxylin and eosin (Muto, Japan). Pathological changes were examined under a microscope (CKX53; Olympus, Tokyo, Japan).
Blood–brain barrier permeability assay
Two hours before sacrifice, mice were injected with 2% Evans blue solution prepared in saline (100 mg kg−1 body weight; Sigma, St. Louis, MO, USA) into the tail vein. The concentration of Evans blue in the brain was determined as described previously, with slight modifications (Chiu and Lai, Reference Chiu and Lai2013), to assess blood–brain barrier (BBB) permeability. The average concentration of Evans blue in the cerebrospinal fluid (CSF) was calculated by measuring absorbance of the CSF at 620 nm using a spectrophotometer (Hitachi U3000; Tokyo, Japan).
Statistical analysis
Statistical analyses were performed by multiple comparisons that were accessed through one-way analysis of variance and using SigmaPlot software (version 10.0; Systat Software Inc., San Jose, CA, USA) with GraphPad Prism 8. Comparisons between 2 groups were performed using the Student's t-test. In all tests, a value of *P < 0.05 was considered statistically significant, while **P < 0.01 and ***P < 0.001 indicated increased statistical significance.
Results
Time-course studies of MMP-9, COX-2, p-NF-κB and HO-1 levels from the brains of mice infected with A. cantonensis
The inflammatory mediators MMP-9, COX-2 and p-NF-κB are associated with brain inflammation. Therefore, we examined the protein levels of MMP-9, COX-2 and p-NF-κB after A. cantonensis infection in a time-dependent manner. Time-course studies for MMP-9 level showed significant increases (P < 0.05) from day 10 to day 25. Furthermore, COX-2 and p-NF-κB levels significantly increased (P < 0.05) from day 6 to day 30 (Fig. 1A).
HO-1 is a cytoprotective enzyme that responds to oxidative and inflammatory stimuli. Therefore, we examined the expression of HO-1 after A. cantonensis infection in a time-dependent manner through western blotting. HO-1 levels were significantly increased (P < 0.05) from day 6 to day 30 (Fig. 1B). The results from 3 repeated and separate experiments were similar.
Effects of ABZ combined with calycosin from the brain of mice infected with A. cantonensis infection
To assess the effects of ABZ, calycosin and ABZ combined with calycosin treatment, we detected changes in the protein levels of MMP-9, COX-2 and p-NF-κB using western blotting. The results showed that MMP-9, COX-2 and p-NF-κB levels were significantly increased in the infection groups compared to the control group. Nevertheless, MMP-9, COX-2 and p-NF-κB levels were significantly lower in the ABZ, calycosin and ABZ combined with calycosin treatment groups, particularly in the ABZ combined with calycosin treatment group, compared with the A. cantonensis-infected mice (Fig. 2A and B). Moreover, HO-1 expression was moderately increased in the infection and ABZ-only treatment groups compared to the control and significantly increased under calycosin or ABZ combined with calycosin treatment compared to the control, infection and ABZ-only treatment groups (Fig. 2C). The results from 3 repeated and separate experiments were similar.
Changes in larvae recovery, Evans blue units, TNF-α and IL-1β from the brain of mice treated with ABZ alone or ABZ combined with calycosin caused by A. cantonensis infection
Larval recovery was significantly increased in infected mice treated with calycosin alone but decreased in ABZ-alone or ABZ–calycosin co-treatment (Fig. 3A). Moreover, BBB permeability was enhanced in mice with eosinophilic meningitis or meningoencephalitis, which may result from A. cantonensis infection, and was detected by performing Evans blue extravasation assay during A. cantonensis infection (Fig. 3B). Additionally, TNF-α and IL-1β are key proinflammatory cytokines in inflammatory diseases (Turner et al., Reference Turner, Nedjai, Hurst and Pennington2014). Therefore, we also assessed the levels of TNF-α (Fig. 3C) and IL-1β (Fig. 3D) in a time-dependent manner, following A. cantonensis infection, using ELISA. The results demonstrated that Evans blue, TNF-α and IL-1β levels were significantly increased in the infection groups compared to the control group. Moreover, Evans blue, TNF-α and IL-1β levels were significantly decreased in the ABZ, calycosin and ABZ plus calycosin treatment groups, especially in the ABZ plus calycosin treatment group, compared with the A. cantonensis-infected mice. The results from 3 repeated and separate experiments were consistent.
Changes in MMP-9, COX-2, p-NF-κB, HO-1 and β-actin protein levels in the brains of mice treated with ABZ combined with calycosin or SnPPIX caused by A. cantonensis infection
To confirm the protective effects of HO-1, we performed additional experiments to assess the effect of SnPPIX, a potent competitive inhibitor of HO-1 (Hyvelin et al., Reference Hyvelin, Maurel, Uzbekov, Motterlini and Lermusiaux2010). The protein levels of MMP-9, COX-2 and p-NF-κB in the treated groups were similar to those observed in Fig. 2. The levels of MMP-9, COX-2 and p-NF-κB were significantly increased and HO-1 levels were moderately increased in the infection groups; however, MMP-9, COX-2 and p-NF-κB levels were significantly decreased and HO-1 levels were significantly increased in the ABZ plus calycosin treatment groups. Additionally, co-treatment with SnPPIX, ABZ and calycosin reversed the effects of ABZ plus calycosin treatment, i.e. increased MMP-9, COX-2 or p-NF-κB and decreased HO-1 expression (Fig. 4). The results from 3 repeated and separate experiments were similar.
Changes in larval recovery, Evans blue, TNF-α and IL-1β levels after treatment with ABZ alone or ABZ–calycosin in the brains of mice during A. cantonensis infection
To confirm the inhibitory effect of SnPPIX on HO-1 activity, we assessed the larval recovery, Evans blue, TNF-α and IL-1β levels. Larval recovery was significantly increased in infected mice treated with calycosin alone but decreased in ABZ-alone or ABZ–calycosin co-treatment groups.
In contrast, larval recovery was decreased by ABZ–calycosin or SnPPIX–ABZ–calycosin co-treatment (Fig. 5A). The Evans blue units (Fig. 5B), TNF-α (Fig. 5C) and IL-1β (Fig. 5D) levels were significantly increased in the infection groups compared with the control group; however, their levels were significantly decreased in the ABZ plus calycosin treatment group. Furthermore, co-treatment with SnPPIX, ABZ and calycosin reversed the effects of ABZ and calycosin. The results from the 3 repeated and separate experiments were similar.
Histopathological examinations
Optical microscopic examination of tissues stained with haematoxylin and eosin showed that eosinophilic meningitis was induced in the infected groups. The results demonstrated severe haemorrhage, severe thickening of the meninges and large-scale infiltration of the subarachnoid space by leucocytes in A. cantonensis-infected mouse brain tissues compared to normal controls. Haemorrhage, meningeal thickness and leucocyte infiltration were moderately reduced by the individual treatment with ABZ or calycosin. However, ABZ in combination with calycosin showed a marked reduction in haemorrhage, meningeal thickness and leucocyte number. In addition, co-treatment with SnPPIX, ABZ and calycosin reversed the effects of ABZ and calycosin (Fig. 6).
Discussion
Angiostrongylus cantonensis causes eosinophilic meningitis in mice that attains a peak at approximately 3 weeks. In parallel with this pathogenesis, infected mice show signs of a gradual increase in inflammation, attaining a peak at the same time (Sugaya and Yoshimura, Reference Sugaya and Yoshimura1988; Sasaki et al., Reference Sasaki, Sugaya, Ishida and Yoshimura1993). Previous studies have shown that TNF-α, IL-1β (Tu and Lai, Reference Tu and Lai2006), MMP-9 (Chen et al., Reference Chen, Lee, Lu, Tseng, Hsu, Chou and Lai2004), COX-2 (Chen et al., Reference Chen, Peng, Shyu, Lan and Lai2021) and NF-κB (Chiu and Lai, Reference Chiu and Lai2013) may participate in the pathogenesis of CNS inflammation during A. cantonensis infection. In this study, significant increases in TNF-α, IL-1β, MMP-9, COX-2 and p-NF-κB levels in brain samples from mice infected with A. cantonensis were demonstrated in a time-dependent manner. In contrast, levels of these inflammatory enzymes decreased in response to treatment with ABZ, a broad-spectrum anthelmintic.
Calycosin is an isoflavonoid and a major bioactive chemical in Huang Qi (Li et al., Reference Li, Zhang and Zhang2011). Furthermore, calycosin can exert neuroprotective and anti-inflammatory effects (Su et al., Reference Su, Huang, Chen, Wang, Pan, Wang, Zhou, Zhou, Liu, Yang, Li and Liu2016; Lu et al., Reference Lu, Day, Kuo, Wang, Ho, Lai, Chen, Yao, Viswanadha, Kuo and Huang2022) and reduce cellular oxidative damage (Guo et al., Reference Guo, Rimbach, Moini, Weber and Packer2002; Lu et al., Reference Lu, Day, Kuo, Wang, Ho, Lai, Chen, Yao, Viswanadha, Kuo and Huang2022). Likewise, our results revealed that calycosin protected mice against A. cantonensis-induced inflammation and reduced the production of inflammatory enzymes. However, its therapeutic effects could not completely suppress the A. cantonensis-induced inflammation, probably owing to the persistence of the parasites even after treatment.
ABZ kills parasites such as the nematode A. cantonensis by blocking the absorption of glucose by the larvae (Hwang and Chen, Reference Hwang and Chen1988; Lakwo et al., Reference Lakwo, Ishih, Terada and Sano1998). Thus far, the drug has shown good results for the treatment of angiostrongyliasis (Hwang and Chen, Reference Hwang and Chen1991). ABZ exhibits marked larvicidal activity against angiostrongyliasis. However, certain studies have revealed that ABZ and mebendazole are not recommended for angiostrongyliasis treatment because they may exacerbate the neurological symptoms as a side-effect (Hidelaratchi et al., Reference Hidelaratchi, Riffsy and Wijesekera2005; Wang et al., Reference Wang, Jung, Chen, Wong, Wan and Wan2006; Wan et al., Reference Wan, Sun, Wu, Yu, Wang, Lin, Li, Wu and Sun2018). Additionally, treatment with ABZ alone in eosinophilic meningitis cannot completely inhibit the inflammatory reaction (Lan et al., Reference Lan, Wang, Hsu, Chen, Lai and Lee2004). Thus, treatment usually involves co-administration of corticosteroids to limit the inflammatory reaction (Chotmongkol et al., Reference Chotmongkol, Sawadpanitch, Sawanyawisuth, Louhawilai and Limpawattana2006, Reference Chotmongkol, Kittimongkolma, Niwattayakul, Intapan and Thavornpitak2009; Diao et al., Reference Diao, Wang, Qi, Li, Zheng and Yin2011). Corticosteroids have been used for a long time in the clinic and have played a useful role in suppressing inflammation in the brain. However, steroids have side-effects such as infection (immunodepression), gastrointestinal symptoms, osteoporosis, weight gain and steroid withdrawal syndrome (Prociv and Turner, Reference Prociv and Turner2018; McAuliffe et al., Reference McAuliffe, Fortin Ensign, Larson, Bavaro, Yetto, Cathey, Mukaigawara, Narita, Ohkusu, Quast and Volk2019). To increase the survival rate and quality of treatment, it may be helpful to replace steroids with other anti-neuroinflammatory agents. Therefore, the present study focused on the evaluation of calycosin. The application of combination therapy with ABZ and calycosin is a prudent course of action. This combination therapy effectively suppressed excessive inflammation compared to treatment with calycosin or ABZ alone.
HO represents a class of microsomal enzymes that includes HO-1, HO-2 and HO-3. HO degrades the prooxidant haem to carbon monoxide, biliverdin (subsequently reduced to bilirubin) and ferrous iron (Maines, Reference Maines1997; Turkseven et al., Reference Turkseven, Kruger, Mingone, Kaminski, Inaba, Rodella, Ikehara, Wolin and Abraham2005). HO-1 activity is significantly induced by numerous stimuli, including haem, heavy metals, hormones, oxidative stress (Platt and Nath, Reference Platt and Nath1998; Novotny and Vitek, Reference Novotny and Vitek2003; Lu et al., Reference Lu, Day, Kuo, Wang, Ho, Lai, Chen, Yao, Viswanadha, Kuo and Huang2022) and traumatic brain injury (Okubo et al., Reference Okubo, Xi, Keep, Muraszko and Hua2013). HO-1 induction has been shown to confer protection, whereas its abrogation has been revealed to accelerate cellular injuries (Akagi et al., Reference Akagi, Takahashi and Sassa2002). Additionally, HO-1 modulates brain inflammation and apoptosis in mice with angiostrongyliasis (Chen et al., Reference Chen, Lan and Lai2022). Our results indicated that HO-1 level was slightly increased in the A. cantonensis infection and ABZ treatment groups. Moreover, co-treatment with ABZ and calycosin suppressed the expression of inflammatory cytokines and A. cantonensis-induced inflammation and significantly upregulated HO-1 expression, indicating that HO-1 may play a crucial role in the progression of A. cantonensis-induced inflammation. To better understand the role of HO-1 induced by calycosin, A. cantonensis-infected mice were pre-treated with SnPPIX, a well-characterized HO-1 inhibitor. Our results demonstrated that, with the combination of SnPPIX and ABZ–calycosin treatment, SnPPIX reversed the ABZ–calycosin-induced upregulation of expression of HO-1 and inflammatory cytokines in A. cantonensis-infected mice. This finding suggests that calycosin may act as an HO-1 activator that upregulates and maintains HO-1 expression after A. cantonensis infection. These results indicate that modulation of HO-1 and NF-κB activation after calycosin treatment protects against inflammation in A. cantonensis-infected mice. However, the role of calycosin in A. cantonensis-infected mice remains unclear. As the current study was limited to in vivo systems, future work is required to evaluate the in vitro effects and molecular mechanisms of calycosin.
Conclusions
Our study is the first to show that calycosin exerts anti-inflammatory effects in A. cantonensis-infected mice. The results provide evidence that ABZ–calycosin co-treatment effectively suppresses inflammatory mediator production and eosinophilic meningitis through the modulation of HO-1 and NF-κB activity, suggesting that the combination therapy with ABZ and calycosin may also reduce the side-effects of ABZ. Our study lays forth a probable explanation for the beneficial effect of calycosin in the prevention of eosinophilic meningitis caused by A. cantonensis. This study was limited to the finding that calycosin attenuates A. cantonensis-induced parasitic meningitis through modulation of HO-1 and NF-κB activation. Future work is required to evaluate the detailed underlying molecular mechanisms linked to the therapeutic efficacy of combination therapy to improve anti-parasitic meningitis effects.
Data availability
The data and material of this study are available for publishing in public.
Author's contributions
C.-Y. L. designed the research, performed the experiments and wrote the manuscript; K.-M. C. and W.-W. K. corrected the manuscript; S.-C. L. and T.-J. H. performed the experiments; C.-Y. L., K.-M. C., P.-T. L., C.-Y. H. and T.-F. W. contributed to new reagents and analytical tool. All authors were involved in editing the manuscript and had approved the submitted final published format.
Financial support
We gratefully acknowledge that this study was supported by grants from the Ministry of Science and Technology (MOST 109-2320-B-303-007), and Hualien Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation) (IMAR-110-01-15).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
All surgical procedures and postoperative care were performed according to the Guide for the Care and Use of Laboratory Animals of the Hualien Tzu Chi Hospital.